title: Dissecting cellulitis of the scalp treated with tumour necrosis factor-α inhibitors: experience with two agents.
authors.affiliation: Department of Dermatology, Heart of England NHS Foundation Trust, Solihull, West Midlands, U.K. yamansouri@gmail.com.
authors.forename: Y
authors.initials: Y
authors.lastname: Mansouri
authors.affiliation: Department of Dermatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands, U.K.
authors.forename: A
authors.initials: A
authors.lastname: Martin-Clavijo
authors.affiliation: University of Birmingham, NIHR Liver BRU and Centre for Liver Research, Birmingham, West Midlands, U.K.
authors.forename: P
authors.initials: P
authors.lastname: Newsome
authors.affiliation: Department of Dermatology, Heart of England NHS Foundation Trust, Solihull, West Midlands, U.K.
authors.forename: M R
authors.initials: MR
authors.lastname: Kaur
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002481:Cellulitis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012536:Scalp Dermatoses / Q000188:drug therapy*; D012873:Skin Diseases, Genetic / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab